The inaugural Peptide Based Therapeutics Summit is a landmark event for experts in peptide-based drug development, covering a wide range of diseases and therapeutic strategies. As technology propels the peptide field forward, this summit offers an unparalleled opportunity for those already leading the way or seeking to expand their knowledge and pipelines. It focuses on cutting-edge topics such as peptide drug conjugates, bicyclic and macro-cyclic peptides, PCSK9 inhibitors, and GLP-1 receptor agonists. Attendees will benefit from peer learning, networking, and insights into accelerating the discovery and development of innovative peptide therapeutics.

Bachem participates in this event.